Supplementary Figure 3 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 64K, Illustrations of the variation in pathologic responses to treatment. Examples of intermediate and no response.
Authors: F. Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Anita Giobbie-Hurder, Michael B. Atkins, Nageatte Ibrahim, Philip Friedlander, Keith T. Flaherty, George F. Murphy, Scott Rodig, Elsa F. Velazquez, Martin C. Mihm, Sara Russell, Pamela J. DiPiro, Jeffrey T. Yap, Nikhil Ramaiya, Annick D. Van den Abbeele, Maria Gargano, David McDermott
Institution: Dana-Farber Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Award: G9000285421
OpenAlex ID: W4362552350